Tuesday, June 15, 2021

Covaxin trials approved in children between 2 and 18 years

Must Read

Novavax says efficacy preserved in participants receiving influenza, Covid-19 vaccines | World News

For breaking news and live news updates, Join us on Whatsapp The company said vaccine efficacy was 87.5% compared...

Pakistan’s Sindh, Khyber Pakhtunkhwa to end 2-day Covid-19 lockdown policy | World News

For breaking news and live news updates, Join us on Whatsapp Businesses in Khyber Pakhtunkhwa will now be allowed...

For breaking news and live news updates, Join us on Whatsapp

Bharat Biotech has received approval from India’s drugs regulator to conduct clinical trials on children for its coronavirus disease (Covid-19) vaccine, Covaxin, making it the first Covid-19 vaccine to be tested on kids in India.

The approval has been granted for testing the vaccine on children between 2 and 18 years of age. The subject expert committee (SEC) of the central drugs standard control organisation (CDSCO) on Tuesday approved trials, with certain conditions, officials aware of the matter confirmed.

“The panel approval is for the phase II/III trials under certain conditions,” an official privy to the matter confirmed, on the condition of anonymity.

Also Read | Scientists race to study variants in India as Covid cases explode

According to reports, the trial is planned to be conducted among 525 participants at multiple locations. The hospitals include All India Institute of Medical Sciences (AIIMS), Delhi, and AIIMS in Patna.

The aim of conducting the trials will be to evaluate the Covaxin vaccine in children for safety, reactogenicity and immunogenicity. All these parameters are necessary for granting approval for use in masses.

Covaxin is the first Make in India Covid-19 vaccine that Bharat Biotech co-developed with the Indian Council of Medical Research (ICMR). It is a whole virion inactivated vaccine.

Bharat Biotech had approached the national drugs regulator with a proposal to test its Covaxin vaccine on children between 5 and 18 years of age, but the company was asked to come back with the efficacy data of its vaccine in adults first before testing the vaccine on children.

It was also asked to submit a revised clinical trials protocol for children in the SEC meeting of CDSCO on February 24.

As part of the SEC recommendation, the company has been asked to submit the interim safety data of phase II clinical trials along with the data safety and management board recommendations to the CDSCO before it intends to proceed to seek permission for the phase III part of the trials.

Currently, Pfizer-BioNTECH Covid-19 vaccine has been approved by US FDA for use on children between 12 and 15 years in the US.

For breaking news and live news updates, like us on Facebook or Whatsapp or follow us on Twitter and Linkedin. Read more on Latest India News on Smart Newsline



Latest News

Sushant Singh Rajput’s sister Meetu remembers him on his death anniversary: ‘Many have brutally used you’ | Bollywood

For breaking news and live news updates, Join us on Whatsapp Sushant Singh Rajput's sister Meetu Singh has shared pictures from the puja held...

Filmmaker Ashutosh Gowariker on 20 years of lagaan, said – Aamir Khan had refused saying that I should not do this film, you can...

For breaking news and live news updates, Join us on Whatsapp EntertainmentBollywoodFilmmaker Ashutosh Gowariker On 20 Years Of Lagaan, Said – Aamir Khan Had...

Dia Mirza: Deep-rooted prejudices make us forget that we are human first | Bollywood

For breaking news and live news updates, Join us on Whatsapp With OTT platforms coming to the fore stronger than before in the last...

EXCLUSIVE: Lagaan is probably my most unprepared performance, says Aamir Khan | Bollywood

For breaking news and live news updates, Join us on Whatsapp Aur Bhuvan ka naam itihaas ke panno mein kahi kho gaya... This concluding...

More Articles Like This